Mangrove Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
SCM
RCM
RJA
AW
WP
Mangrove Partners's BCAT Position: Q2 2023 in Review
Mangrove Partners sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2023, closing a stake of 390,667 shares — an estimated $5.91M sold.
Mangrove Partners first reported a position in BCAT in Q2 2022 and held it in 4 quarters. The position peaked at $5.91M in Q1 2023. 72 funds tracked by Wall St. Rank hold BCAT as of Q2 2023.
- Mangrove Partners reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2023 after selling out during the quarter.
- Mangrove Partners sold 390,667 BlackRock Capital Allocation Term Trust shares in Q2 2023, an estimated $5.91M.
- Mangrove Partners first reported a position in BlackRock Capital Allocation Term Trust in Q2 2022 and held it in 4 quarters.
- Mangrove Partners's BlackRock Capital Allocation Term Trust position peaked at $5.91M in Q1 2023.
- 72 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2023.
Based on Mangrove Partners's 13F filing for Q2 2023, filed 14 Aug 2023.